Fed. Circ. Revives Santarus' Suit Over Par's Generic Zegerid
In a per curiam, precedential opinion, a three-judge panel said that a Delaware federal judge erred in invalidating as obvious two Santarus patents that allow Zegerid to be more easily administered.
"We reverse this portion of the district court judgment and hold that Par did not...
To view the full article, register now.